IL-27 enhances the survival of tumor antigen-specific CD8+ T cells and programs them into IL-10-producing, memory precursor-like effector cells

European Journal of Immunology

Volumn 43, Issue 2, 2013, Pages 468-479

  Liu, Zhenzhen ^a,b   Liu, Jin Qing ^a   Talebian, Fatemeh ^a   Wu, Lai Chu ^b   Li, Shulin ^c   Bai, Xue Feng ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Animal models; CD8 T cells; Cytokines; Tumor immunology

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 27; PROTEIN BCL 6; STAT3 PROTEIN; STEM CELL ANTIGEN 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR ANTIGEN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; CANCER CELL CULTURE; CD8+ T LYMPHOCYTE; CELL SURVIVAL; CYTOKINE PRODUCTION; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PLASMACYTOMA; PRE T LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY;

ANIMALS; ANTIGENS, LY; ANTIGENS, NEOPLASM; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CELL SURVIVAL; IMMUNOLOGIC MEMORY; INTERLEUKIN-10; INTERLEUKINS; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; PROTO-ONCOGENE PROTEINS C-BCL-6; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; UP-REGULATION;

EID: 84873745745     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201242930     Document Type: Article

References (43)

1. Pflanz, S., Timans, J. C., Cheung, J., Rosales, R., Kanzler, H., Gilbert, J., Hibbert, L. et al., IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 2002. 16: 779-790.
2. Pflanz, S., Hibbert, L., Mattson, J., Rosales, R., Vaisberg, E., Bazan, J. F., Phillips, J. H. et al., WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J. Immunol. 2004. 172: 2225-2231.
3. Hibbert, L., Pflanz, S., De Waal Malefyt, R. and Kastelein, R. A., IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells. J. Interferon Cytokine Res. 2003. 23: 513-522.
4. Hunter, C. A., New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 2005. 5: 521-531.
5. Hall, A. O., Silver, J. S. and Hunter, C. A., The immunobiology of IL-27. Adv. Immunol. 2012. 115: 1-44.
6. Hisada, M., Kamiya, S., Fujita, K., Belladonna, M. L., Aoki, T., Koyanagi, Y., Mizuguchi, J. et al., Potent antitumor activity of interleukin-27. Cancer Res. 2004. 64: 1152-1156.
7. Salcedo, R., Stauffer, J. K., Lincoln, E., Back, T. C., Hixon, J. A., Hahn, C., Shafer-Weaver, K. et al., IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors: role for CD8+ T cells. J. Immunol. 2004. 173: 7170-7182.
8. Chiyo, M., Shimozato, O., Iizasa, T., Fujisawa, T. and Tagawa, M., Antitumor effects produced by transduction of dendritic cells-derived heterodimeric cytokine genes in murine colon carcinoma cells. Anticancer Res. 2004. 24: 3763-3767.
9. Salcedo, R., Hixon, J. A., Stauffer, J. K., Jalah, R., Brooks, A. D., Khan, T., Dai, R. M. et al., Immunologic and therapeutic synergy of IL-27 and IL-2: enhancement of T-cell sensitization, tumor-specific CTL reactivity and complete regression of disseminated neuroblastoma metastases in the liver and bone marrow. J. Immunol. 2009. 182: 4328-4338.
10. Zhu, S., Lee, D. A. and Li, S., IL-12 and IL-27 sequential gene therapy via intramuscular electroporation delivery for eliminating distal aggressive tumors. J. Immunol. 2010. 184: 2348-2354.
11. Shinozaki, Y., Wang, S., Miyazaki, Y., Miyazaki, K., Yamada, H., Yoshikai, Y., Hara, H. et al., Tumor-specific cytotoxic T-cell generation and dendritic cell function are differentially regulated by interleukin 27 during development of anti-tumor immunity. Int. J. Cancer 2009. 124: 1372-1378.
12. Morishima, N., Mizoguchi, I., Okumura, M., Chiba, Y., Xu, M., Shimizu, M., Matsui, M. et al., A pivotal role for interleukin-27 in CD8+ T-cell functions and generation of cytotoxic T lymphocytes. J. Biomed. Biotechnol. 2010. 2010: 605483.
13. Morishima, N., Owaki, T., Asakawa, M., Kamiya, S., Mizuguchi, J. and Yoshimoto, T., Augmentation of effector CD8+ T-cell generation with enhanced granzyme B expression by IL-27. J. Immunol. 2005. 175: 1686-1693.
14. Schneider, R., Yaneva, T., Beauseigle, D., El-Khoury, L. and Arbour, N., IL-27 increases the proliferation and effector functions of human naive CD8+ T lymphocytes and promotes their development into Tc1 cells. Eur. J. Immunol. 2011. 41: 47-59.
15. Batten, M., Kljavin, N. M., Li, J., Walter, M. J., de Sauvage, F. J. and Ghilardi, N., Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells. J. Immunol. 2008. 180: 2752-2756.
16. Stumhofer, J. S., Silver, J. S., Laurence, A., Porrett, P. M., Harris, T. H., Turka, L. A., Ernst, M. et al., Interleukins 27 and 6 induce STAT3-mediated T-cell production of interleukin 10. Nat. Immunol. 2007. 8: 1363-1371.
17. Mumm, J. B., Emmerich, J., Zhang, X., Chan, I., Wu, L., Mauze, S., Blaisdell, S. et al., IL-10 elicits IFNgamma-dependent tumor immune surveillance. Cancer Cell 2011. 20: 781-796.
18. Tanikawa, T., Wilke, C. M., Kryczek, I., Chen, G. Y., Kao, J., Nunez, G. and Zou, W., Interleukin-10 ablation promotes tumor development, growth, and metastasis. Cancer Res. 2012. 72: 420-429.
19. Groux, H., Cottrez, F., Rouleau, M., Mauze, S., Antonenko, S., Hurst, S., McNeil, T. et al., A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. J. Immunol. 1999. 162: 1723-1729.
20. Wang, L., Liu, J. Q., Talebian, F., El-Omrani, H. Y., Khattabi, M., Yu, L. and Bai, X. F., Tumor expression of CD200 inhibits IL-10 production by tumor-associated myeloid cells and prevents tumor immune evasion of CTL therapy. Eur. J. Immunol. 2010. 40: 2569-2579.
21. Wang, L. X., Talebian, F., Liu, J. Q., Khattabi, M., Yu, L. and Bai, X. F., IL-10 contributes to the suppressive function of tumour-associated myeloid cells and enhances myeloid cell accumulation in tumours. Scand. J. Immunol. 2012. 75: 273-281.
22. Rowbottom, A. W., Lepper, M. A., Garland, R. J., Cox, C. V. and Corley, E. G., Interleukin-10-induced CD8 cell proliferation. Immunology 1999. 98: 80-89.
23. Fujii, S., Shimizu, K., Shimizu, T. and Lotze, M. T., Interleukin-10 promotes the maintenance of antitumor CD8(+) T-cell effector function in situ. Blood 2001. 98: 2143-2151.
24. Kaech, S. M., Hemby, S., Kersh, E. and Ahmed, R., Molecular and functional profiling of memory CD8 T-cell differentiation. Cell 2002. 111: 837-851.
25. Cui, W., Liu, Y., Weinstein, J. S., Craft, J. and Kaech, S. M., An interleukin-21-interleukin-10-STAT3 pathway is critical for functional maturation of memory CD8+ T cells. Immunity 2011. 35: 792-805.
26. Real, P. J., Sierra, A., De Juan, A., Segovia, J. C., Lopez-Vega, J. M. and Fernandez-Luna, J. L., Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells. Oncogene 2002. 21: 7611-7618.
27. Bhattacharya, S., Ray, R. M. and Johnson, L. R., STAT3-mediated transcription of Bcl-2, Mcl-1 and c-IAP2 prevents apoptosis in polyamine-depleted cells. Biochem. J. 2005. 392: 335-344.
28. Porter, A. G. and Janicke, R. U., Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 1999. 6: 99-104.
29. Siegel, A. M., Heimall, J., Freeman, A. F., Hsu, A. P., Brittain, E., Brenchley, J. M., Douek, D. C. et al., A critical role for STAT3 transcription factor signaling in the development and maintenance of human T-cell memory. Immunity 2011. 35: 806-818.
30. Murali-Krishna, K., Lau, L. L., Sambhara, S., Lemonnier, F., Altman, J. and Ahmed, R., Persistence of memory CD8 T cells in MHC class I-deficient mice. Science 1999. 286: 1377-1381.
31. Liu, J. Q., Liu, Z., Zhang, X., Shi, Y., Talebian, F., Carl, J. W., Jr., Yu, C. et al., Increased Th17 and regulatory T-cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis. J. Immunol. 2012. 188: 3099-3106.
32. Liu, J. Q. and Bai, X. F., Overcoming immune evasion in T-cell therapy of cancer: lessons from animal models. Curr. Mol. Med. 2008. 8: 68-75.
33. Noble, A., Giorgini, A. and Leggat, J. A., Cytokine-induced IL-10-secreting CD8 T cells represent a phenotypically distinct suppressor T-cell lineage. Blood 2006. 107: 4475-4483.
34. Trandem, K., Zhao, J., Fleming, E. and Perlman, S., Highly activated cytotoxic CD8 T cells express protective IL-10 at the peak of coronavirus-induced encephalitis. J. Immunol. 2011. 186: 3642-3652.
35. Zhang, Y., Joe, G., Hexner, E., Zhu, J. and Emerson, S. G., Host-reactive CD8+ memory stem cells in graft-versus-host disease. Nat. Med. 2005. 11: 1299-1305.
36. Gattinoni, L., Zhong, X. S., Palmer, D. C., Ji, Y., Hinrichs, C. S., Yu, Z., Wrzesinski, C. et al., Wnt signaling arrests effector T-cell differentiation and generates CD8+ memory stem cells. Nat. Med. 2009. 15: 808-813.
37. Foulds, K. E., Rotte, M. J. and Seder, R. A., IL-10 is required for optimal CD8 T-cell memory following Listeria monocytogenes infection. J. Immunol. 2006. 177: 2565-2574.
38. Takemoto, N., Intlekofer, A. M., Northrup, J. T., Wherry, E. J. and Reiner, S. L., Cutting edge: IL-12 inversely regulates T-bet and eomesodermin expression during pathogen-induced CD8+ T-cell differentiation. J. Immunol. 2006. 177: 7515-7519.
39. Oestreich, K. J., Huang, A. C. and Weinmann, A. S., The lineage-defining factors T-bet and Bcl-6 collaborate to regulate Th1 gene expression patterns. J. Exp. Med. 2011. 208: 1001-1013.
40. Kryczek, I., Zhao, E., Liu, Y., Wang, Y., Vatan, L., Szeliga, W., Moyer, J. et al., Human TH17 cells are long-lived effector memory cells. Sci. Transl. Med. 2011. 3: 104ra100.
41. Muranski, P., Borman, Z. A., Kerkar, S. P., Klebanoff, C. A., Ji, Y., Sanchez-Perez, L., Sukumar, M. et al., Th17 cells are long lived and retain a stem cell-like molecular signature. Immunity 2011. 35: 972-985.
42. Joshi, P. S., Liu, J. Q., Wang, Y., Chang, X., Richards, J., Assarsson, E., Shi, F. D. et al., Cytokine-induced killer T cells kill immature dendritic cells by TCR-independent and perforin-dependent mechanisms. J. Leukoc. Biol. 2006. 80: 1345-1353.
43. Liu, J. Q., Joshi, P. S., Wang, C., El-Omrani, H. Y., Xiao, Y., Liu, X., Hagan, J. P. et al., Targeting activation-induced cytidine deaminase overcome tumor evasion of immunotherapy by CTLs. J. Immunol. 2010. 184: 5435-5443.